STOCK TITAN

Agilent Technologies Inc. - A STOCK NEWS

Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.

Agilent Technologies Inc., originally spun out of Hewlett-Packard in 1999, has evolved into a leading firm in the life sciences and diagnostics sector. The company specializes in creating advanced measurement technologies that serve a vast range of customers across various industries.

The company's core business revolves around three main segments: life science and applied tools, cross lab (which includes consumables and services related to life sciences and applied tools), and diagnostics and genomics. These segments collectively cater to a broad spectrum of markets, including biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government-related organizations.

Agilent's geographical reach is extensive, with significant operations in the U.S. and China. The company is committed to addressing global trends impacting human health and the environment and continuously anticipates future scientific needs.

Agilent provides comprehensive laboratory solutions that enhance the efficiency of laboratories, from sample preparation to data interpretation and management. Their instruments, software, services, and consumables are designed to meet the most complex laboratory demands, empowering scientists and researchers worldwide to make impactful discoveries and improvements in various fields.

Recent achievements include advancements in biopharmaceutical technology, collaborations with leading research institutions, and the launch of state-of-the-art diagnostic tools. The company also emphasizes sustainable practices and innovations aimed at improving human health and environmental outcomes.

Rhea-AI Summary

Agilent Technologies, Inc. (NYSE: A) has declared a quarterly dividend of 21 cents per share, scheduled for payment on April 27, 2022. Shareholders on record as of April 5, 2022 will receive this dividend. The company generated revenue of $6.32 billion in fiscal 2021 and employs approximately 17,000 people. Future dividends will be determined by Agilent’s board of directors and may vary based on company performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
dividends
-
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) showcased innovative laboratory automation solutions at the SLAS2022 International Conference in Boston, Massachusetts, from February 5 to 9, 2022. Their modular automation solutions enhance workflows in cell analysis, mass spectrometry, and genomics, leading to improved sample preparation, accuracy, and efficiency. Key highlights include the BioTek BioSpa Live Cell Analysis System and the compliant VWorks software for integrated laboratory automation. Agilent reported $6.32 billion in revenue for fiscal 2021, indicating strong market presence and innovation capacity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.47%
Tags
none
-
Rhea-AI Summary

Agilent Technologies (NYSE: A) has signed a Research Collaboration Agreement with the Singapore Institute of Food and Biotechnology Innovation (SIFBI) to advance food research over the next two years. This partnership supports Singapore's goal to produce 30% of its nutritional needs by 2030, enhancing food resilience and security. Agilent will provide analytical technology and support for developing efficient methods for food innovation. With over 800 local scientists and engineers, Agilent aims to boost Singapore's food innovation ecosystem, ultimately promoting healthier, sustainable food options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
none
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) has announced the launch of the Agilent Seahorse XF Pro Analyzer, designed to enhance cellular metabolism analysis in the pharma and biopharma sectors. The XF Pro offers improved performance and user accessibility, facilitating real-time monitoring of live cells. This new technology aims to help researchers identify drug targets and optimize disease models while ensuring better data precision in immunotherapy and preclinical safety assessments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
none
-
News
Rhea-AI Summary

RTX A/S has announced new additions to its Sheerlink TM wireless solutions during the NAMM 'Believe in Music Week' event on January 20-21, 2022. These innovations allow manufacturers to double the number of active TX devices on one receiver while maintaining usability, latency, and audio quality at minimal additional costs. Enhanced features include an auxiliary audio channel for increased versatility and deployment using RTX1290 or RTX1090 modules, simplifying design processes amidst component supply challenges. RTX aims to expand product portfolios for customers through these advancements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
none
-
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) will announce its first-quarter fiscal year 2022 financial results on February 22, 2022, after market close. A live webcast of the investor conference call will take place the same day at 1:30 p.m. Pacific time. Agilent reported a revenue of $6.32 billion in fiscal 2021 and is recognized as a leader in life sciences and diagnostics, employing around 17,000 people globally. Access to the webcast will be available on Agilent's investor relations website for 90 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
conferences earnings
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.01%
Tags
none
-
Rhea-AI Summary

Nicoya Lifesciences has secured a $20 million Series A extension led by Whitecap Venture Partners, with contributions from Agilent Technologies and others. This funding boosts the development of their Alto™ platform, which enhances protein characterization and aims to expand into new international markets. This extension increases Nicoya's total funding to $35 million, supporting over 500 researchers globally. Investors recognize the potential of Nicoya's innovative digital proteomics solutions in transforming life sciences.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.27%
Tags
none
-
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) will present at two major healthcare conferences: the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference on January 6, 2022 at 11 a.m. ET and the J.P. Morgan 40th Annual Healthcare Conference on January 11, 2022 at 4:30 p.m. ET. Presentations will be made by CEO Mike McMullen and CFO Bob McMahon. Both events will be webcast, and further details can be found on Agilent's Investor Relations page. The company reported $6.32 billion in revenue for fiscal 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.82%
Tags
conferences
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) has introduced compatibility of its Cary 3500 UV-Vis Spectrophotometer with the Agilent OpenLab software suite. This integration facilitates secure data management and compliance with global regulatory standards, addressing concerns highlighted in a recent survey about data integrity in pharma labs. The system enhances data security and improves efficiency by allowing simultaneous data collection and calibration in under five seconds. Agilent aims to support GMP labs in minimizing audit risks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.43%
Tags
none

FAQ

What is the current stock price of Agilent Technologies (A)?

The current stock price of Agilent Technologies (A) is $130.31 as of October 31, 2024.

What is the market cap of Agilent Technologies (A)?

The market cap of Agilent Technologies (A) is approximately 37.8B.

What does Agilent Technologies Inc. specialize in?

Agilent specializes in life sciences, diagnostics, and measurement technologies, providing advanced solutions and services for laboratories.

When was Agilent Technologies Inc. founded?

Agilent Technologies was spun out of Hewlett-Packard in 1999.

What are the main business segments of Agilent Technologies Inc.?

Agilent operates in three main segments: life science and applied tools, cross lab, and diagnostics and genomics.

Which industries does Agilent Technologies Inc. serve?

Agilent serves industries such as biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government organizations.

Where are Agilent Technologies Inc.'s main operations located?

Agilent's main operations are located in the U.S. and China.

What recent achievements has Agilent Technologies Inc. made?

Recent achievements include advancements in biopharmaceutical technology, collaborations with research institutions, and new diagnostic tools.

How does Agilent Technologies Inc. contribute to laboratory efficiency?

Agilent enhances laboratory efficiency through comprehensive solutions for sample preparation, data interpretation, and management.

What sustainable practices does Agilent Technologies Inc. emphasize?

Agilent focuses on innovations that improve human health and environmental outcomes, emphasizing sustainability in its practices.

Why do scientists and researchers trust Agilent Technologies Inc.?

Scientists and researchers trust Agilent for its reliable solutions that meet complex laboratory demands and enable significant insights.

What kind of global issues does Agilent Technologies Inc. address?

Agilent addresses global issues related to human health and the environment, anticipating future scientific needs.

Agilent Technologies Inc.

NYSE:A

A Rankings

A Stock Data

37.81B
291.76M
0.27%
92.28%
1.13%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States of America
SANTA CLARA